Abstract
Purpose of Review
Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with recent literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options.
Recent Findings
Numerous case reports have been published the last 5 years on secondary sclerosing cholangitis. We have divided them into infectious, drug-induced, ischemic, obstructive, and autoimmune etiologies. The bulk of the literature describes secondary sclerosing cholangitis in the critically ill patient.
Summary
Secondary sclerosing cholangitis due to drugs or autoimmune causes seem to have the best prognosis. However, causes such as critical illness seem to have worse outcomes.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of mportance
Hubers LM, Beuers U. How to diagnose immunoglobulin G4-associated cholangitis: the jack-of-all-trades in the biliary tract. Viszeralmedizin. 2015 Jun;31(3):185–8.
Wiencke K, Boberg KM. Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):786–91.
Imam MH, Talwalkar JA, Lindor KD. Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management. Clin Liver Dis. 2013 May;17(2):269–77.
Chang W-T, Lin N-C, Hsia C-Y, Liu C-S, Tsai H-L, Loong C-C. Liver transplantation for a renal transplantation recipient with secondary sclerosing cholangitis by choledochoduodenal fistula. Asian J Surg. 2012 Jan;35(1):49–52.
Gromski MA, Fogel EL, Vuppalanchi R. Secondary Sclerosing cholangitis from spontaneous choledochoduodenal fistula. Clin Gastroenterol Hepatol. 2017 Mar;15(3):e71–2.
Frei P, Misselwitz B, Prakash MK, Schoepfer AM, Prinz Vavricka BM, Müllhaupt B, et al. Late biliary complications in human alveolar echinococcosis are associated with high mortality. World J Gastroenterol. 2014 May 21;20(19):5881–8.
Gudnason HO, Björnsson HK, Gardarsdottir M, Thorisson HM, Olafsson S, Bergmann OM, et al. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Dig Liver Dis. 2015 Jun;47(6):502–7.
Lo RSC, Krishnamoorthy R, Freeman JG, Austin AS. Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series. Singap Med J. 2011 Mar;52(3):e52–5.
Turkish A, Luo JJ, Lefkowitch JH. Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis. Hepatol Baltim Md. 2013 Aug;58(2):825–7.
El Hajj II, Malik SM, Alwakeel HR, Shaikh OS, Sasatomi E, Kandil HM. Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World J Gastroenterol. 2009 Aug 21;15(31):3937–9.
Nayudu SK, Badipatla S, Niazi M, Balar B. Cholestatic hepatitis with small duct injury associated with celecoxib. Case Rep Med. 2013;2013:315479.
Jin S, Shi X-J, Sun X-D, Wang S-Y, Wang G-Y. Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma. World J Gastroenterol. 2014 Dec 14;20(46):17680–5.
Fan DS, Sorser SA, Gamarra RM. Secondary Sclerosing cholangitis due to gallbladder adenocarcinoma. Case Rep Gastroenterol. 2013 Jan;7(1):134–9.
Ben Slama Trabelsi A, Issaoui D, Ksiaa M, Souguir A, Mama N, Brahem A, et al. Sclerosing cholangitis in Behçet’s disease. Case Rep Med. 2013;2013:692980.
Momah N, Otesile A, Pawa R, Shedlofsky S. Sarcoidosis presenting as necrotizing sarcoid granulomatosis of the liver, sclerosing cholangitis, and gastric ulcer. ACG Case Rep J. 2014 Apr;1(3):164–6.
Abedi SH, Ghassami M, Molaei M, Mohsenifar Z, Mohammad Alizadeh AH. Secondary sclerosing cholangitis and Hodgkin’s lymphoma. Clin Med Insights Case Rep. 2015;8:83–7.
Kirchner GI, Rümmele P. Update on Sclerosing cholangitis in critically ill patients. Viszeralmedizin. 2015 Jun;31(3):178–84.
Voigtländer T, Jaeckel E, Lehner F, Manns MP, TO L. Liver transplantation for critically ill patients with secondary sclerosing cholangitis: outcome and complications. Liver Transpl. 2015 Oct;21(10):1295–9.
Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Hetzer R, Schaffartzik W, et al. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit Care. 2015 Mar 31;19:131.
Lin T, Qu K, Xu X, Tian M, Gao J, Zhang C, et al. Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience. Front Med. 2014 Mar;8(1):118–26.
• Weig T, Schubert MI, Gruener N, Dolch ME, Frey L, Miller J, et al. Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS. Eur J Med Res. 2012 Dec 22;17:30. This study looks at a specific group of patients with severe acute respiratory distress syndrome and compares those with and without secondary sclerosing cholangitis.
Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, et al. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy. 2012 Nov;44(11):1055–8.
Ben-Ari Z, Levingston D, Weitzman E, Haviv-Yadid Y, Cohen-Ezra O, Weiss P, et al. Secondary sclerosing cholangitis following major burn. Ann Hepatol. 2015 Oct;14(5):695–701.
• Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Eurich D, Faber W, et al. Secondary sclerosing cholangitis in critically ill patients: clinical presentation, cholangiographic features, natural history, and outcome: A series of 16 cases. Medicine (Baltimore). 2015 Dec;94(49):e2188. A thorough evaluation of patients with secondary sclerosing cholangitis from critical illness, with examination of the natural history and outcomes.
Voigtländer T, Leuchs E, Vonberg R-P, Solbach P, Manns MP, Suerbaum S, et al. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. J Inf Secur. 2015 May;70(5):483–90.
Voigtländer T, Alten T, Lehner F, Strassburg CP, Manns MP, Lankisch TO. Secondary sclerosing cholangitis following liver transplantation: a rare cause for graft failure. Z Gastroenterol. 2013 Mar;51(3):296–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Rolando Leal and John Brooling declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Pancreas and Biliary Tract
Rights and permissions
About this article
Cite this article
Brooling, J., Leal, R. Secondary Sclerosing Cholangitis: a Review of Recent Literature. Curr Gastroenterol Rep 19, 44 (2017). https://doi.org/10.1007/s11894-017-0583-8
Published:
DOI: https://doi.org/10.1007/s11894-017-0583-8